Apogee Therapeutics Current Assets

As of the most recent data (March 2026), APGE shows a current assets of $1.1B. That compares with $520M in the prior-year period — up 105.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, APGE's current assets is now $1.1B (was $520M) — a 105.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Apogee Therapeutics is outperforming or lagging.

Tracking APGE's current assets over time shows whether Apogee Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1B That compares with $520M in the prior-year period — up 105.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Apogee Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $1.1B) with ownership activity and broader fundamentals.